Navigation Links
Palatin Technologies Completes Enrollment in Phase 2B Bremelanotide Female Sexual Dysfunction Trial
Date:3/8/2012

sfunction (FSD) is a multi-factorial condition that has anatomical, physiological, medical, psychological and social components. FSD includes four disorders: hypoactive sexual desire disorder, female sexual arousal disorder, sexual pain disorder and orgasmic disorder. To establish a diagnosis of FSD, one or more of these disorders must be associated with personal distress, as determined by the affected women. Approximately 40 million American women are affected by FSD. The National Health and Social Life Survey, a probability sample study of sexual behavior in a demographically representative cohort of United States adults ages 18 to 59, found that approximately 43% of women suffer from some form of FSD, with up to about 15% having associated personal distress required to establish a diagnosis of FSD.

There are no drugs in the United States approved for FSD indications.

Bremelanotide for Sexual Dysfunction

Palatin is developing subcutaneously administered bremelanotide for the treatment of FSD in premenopausal women in patients non-responsive to current therapies. Bremelanotide, which is a melanocortin agonist (a compound which binds to a cell receptor and triggers a response) drug candidate, is a synthetic peptide analog of the naturally occurring hormone alpha-MSH (melanocyte-stimulating hormone).

About Palatin Technologies

Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at http://www.palatin.com

Forward-looking Statements

Statements in this pres
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
2. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
3. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
4. Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America
5. Palatin Technologies to Present at 8th Annual BIO Investor Forum
6. Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men
7. Palatin Technologies, Inc. To Raise $2.6 Million Dollars in Registered Direct Offering
8. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
9. Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men
10. Palatin Technologies to Present at Rodman & Renshaw Annual Global Investment Conference
11. Palatin Technologies to Present at 9th Annual BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ReportsnReports.com adds Global Medical ... forecasts as well as Global Medical Simulation Market ... collection of its library. Complete 2015 ... spread across 164 pages, talking about 7 major ... is now available at http://www.reportsnreports.com/reports/407046-global-medical-simulation-industry-report-2015.html . ...
(Date:8/3/2015)... , Aug. 3, 2015 OmniSeq, LLC ... Institute to the OmniSeq SM Genomic Network.  ... Cancer Institute (RPCI) and announced it was making ... a physician-driven, collaborative approach to genomic diagnostics that ... Cancer Institute is a rapidly expanding, multidisciplinary cancer ...
(Date:8/3/2015)... Aug. 3, 2015 Ortho Clinical Diagnostics (OCD) ... named Chief Corporate Brand and Communications Officer, effective immediately. ... team, Bouryal will lead the company,s worldwide corporate brand ... transition to an independent company by adding sites in ... and Chief Executive Officer Dr. Martin Madaus . ...
Breaking Medicine Technology:Medical Simulation Market to see 14% CAGR to 2019 2Medical Simulation Market to see 14% CAGR to 2019 3Medical Simulation Market to see 14% CAGR to 2019 4Medical Simulation Market to see 14% CAGR to 2019 5Medical Simulation Market to see 14% CAGR to 2019 6OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 2OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 3Ortho Clinical Diagnostics Appoints Kristie Bouryal Chief Corporate Brand and Communications Officer 2
(Date:8/4/2015)... ... August 04, 2015 , ... Many men are confused ... subject, Renew Man™ is standing up as a voice of authority for men seeking ... healthy aging industry with special experience and expertise in the safe and effective treatment ...
(Date:8/4/2015)... ... 2015 , ... Buckeye Health Plan is reminding parents to ... covered for members under the Healthchek program . , “Many schools have ... immunizations may not be allowed to attend when school begins in August,” said ...
(Date:8/4/2015)... ... August 04, 2015 , ... SanusEO, the healthcare industry innovator ... executive leadership team as Senior Vice President of Sales and Marketing. Mr. McCalley ... global markets with a special emphasis on the healthcare industry. , Today, patients ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... T.E.N., an ... for vendor participating in The ISE® Lions’ Den and Jungle Lounge 2015, which will ... in Las Vegas. , During the event, eight emerging security vendors, known as “Gazelles,” ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... finds the North America IT reseller channel will grow at least 6 percent ... of their 2014 pace and greater than their OEM/vendor partners. , The ...
Breaking Medicine News(10 mins):Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 2Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 3Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 2Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 4Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 3
... Merck is in trouble again. The Federal Drug Administration of U.S ... was pulled out of the market due to safety reasons. ... same class of drugs as Vioxx ,was voted out 20-1 ... Vioxx from the market in September 2004 after research showed that ...
... can be increasingly used to improve patient care. In a recent ... around 2,250 babies in US alone who succumb to sudden infant ... assistant at the University of Texas has come up with a ... , ,Hung Cao, along with his friends developed a device ...
... Fiorillo noticed that her daughter Bianca could not seem to ... She seemed slower at doing things compared to the other ... on diagnoses it was found that she has CMT, Charcot-Marie-Tooth ... and her brother Tony too suffered from it. ...
... therapy for coronary artery disease is four times more likely ... same medical history. ,Historically, studies have shown ... men, but it has remained unclear how much less effective ... pharmacist and adjunct clinical instructor at the University of Michigan ...
... A former official of the Mets, a leading baseball team ... federal court in San Francisco to distributing// performance-enhancing drugs to ... a decade. ,Kirk Radomski, 37, who had worked ... admitted to selling banned drugs, including anabolic steroids, amphetamines and ...
... may be as important to your health as the food ... toxins that might soon become// as important a risk factor ... ,This class of toxins, called advanced glycation end ... of grilled, fried, or broiled animal products, such as meats ...
Cached Medicine News:Health News:Arcoxia Slammed –Nothing Better Than Vioxx Says FD 2Health News:RFID Use can Avoid Sudden Infant Death Syndrome 2Health News:Cure for CMT 2Health News:Aspirin Therapy for Heart Disease Found More Effective for Men Than Women 2Health News:Aspirin Therapy for Heart Disease Found More Effective for Men Than Women 3Health News:Former Official Confesses He Had Sold Steroids to Leading Baseball Players 2Health News:Food Preparation may Play a Bigger Role in Chronic Disease 2Health News:Food Preparation may Play a Bigger Role in Chronic Disease 3Health News:Food Preparation may Play a Bigger Role in Chronic Disease 4
... adjusted for perfect focus where it's needed ... This, along with Keeler's wide angle light ... the patient's pupil size, you will see ... Lithium-ion technology provides a longer life battery ...
... ophthalmoscopes are individually adjusted for perfect focus ... not on paper. This, along with Keeler's ... ensures that whatever the patient's pupil size, ... field of view. Lithium-ion technology provides a ...
The Beta 200S combines Heine's patented aspherical optics (U.S. Pat. 4.963.014) and a single-step Rekoss disk with a range of 36 to +38 dpt. to provide perfectly-focused images even in cases of high ...
A full function instrument at an economical price....
Medicine Products: